Patent Assignment
Reel/Frame 062779/0928
Assignment of Assignor's Interest
Recorded: 2023-02-23
Pages: 5
Assignor
CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
Executed: 2021-06-02
Assignee
CELLULAR BIOMEDICINE GROUP HK LIMITED
ROOM 417, 4TH FLOOR, LIPPO CENTRE, TOWER TWO, NO.89 QUEENSWAY, ADMIRALTY, HONG KONG, CHINA
Covered Property
(1)
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application:
18/173,187 →
Publication:
US 2023/0242613
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 23, 2023
From: YAO, YIHONG; HUANG, JIAQI; ZHU, SHIGUI; ZHU, WEI
To: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.; CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
Reel/Frame 062779/0784 →
Assignment of Assignor's Interest
Feb 23, 2023
From: CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 062780/0017 →
Assignment of Assignor's Interest
Feb 23, 2023
From: CELLULAR BIOMEDICINE GROUP HK LIMITED
To: CELLULAR BIOMEDICINE GROUP, INC.
Reel/Frame 062780/0143 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →